Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease

11Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN) may serve as a model for Parkinson disease (PD) since many PKAN patients suffer from parkinsonism and both conditions lead to iron accumulation in the basal ganglia. We screened the gene coding for pantothenate kinase 2 (PANK2) for sequence variants in PD. We found no mutations in 67 PD patients with affected sibs or early-onset disease. Moreover, PANK2 polymorphisms were not associated with late-onset idiopathic PD in 339 patients. We conclude that PANK2 variants exert, if any, only a very small effect in the genetic risk of PD. © 2005 Elsevier Ireland Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Klopstock, T., Elstner, M., Lücking, C. B., Müller-Myhsok, B., Gasser, T., Botz, E., … Hörtnagel, K. (2005). Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease. Neuroscience Letters, 379(3), 195–198. https://doi.org/10.1016/j.neulet.2004.12.061

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free